ArticleInternational ophthalmology2025
Combined pars plana vitrectomy and silicone oil injection for the treatment of acute postoperative infectious endophthalmitis.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the efficacy of early pars plana vitrectomy (PPV) and silicone oil (SO) tamponade for treating acute post-phacoemulsification infectious endophthalmitis.
methodsThis retrospective study included 44 eyes of 44 patients who developed early endophthalmitis after uneventful phacoemulsification. PPV with SO tamponade was performed within 24 h of presentation.
resultsA significant improvement in logMAR visual acuity (VA) was reported in our patients; (2.595 ± 0.249 at baseline compared to 1.052 ± 0.462 at final visit), with P value 0.0001. SO was removed in all cases after 4-9 months (6 ± 1.3) and all patients continued follow-up for at least 6 months after SO removal (15.4 ± 6.5). Postoperative complications included; three eyes (6.8%) developing severe proliferative vitreoretinopathy (PVR), four eyes (9.1%) developing inferior retinal detachment (RD) under SO, Two eyes (4.5%) developing pupillary block glaucoma and two eyes (4.5%) suffered from recurrent RD after SO removal.
conclusionEarly PPV with SO tamponade for the treatment of acute endophthalmitis after phacoemulsification has good visual outcomes and lower complication rates if performed early within 24 h of patient presentation.
Indexed as
Identifiers
39920475What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.